L. Faivre, R. Gorlin, and M. Wirtz, In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome, Journal of Medical Genetics, vol.40, issue.1, pp.34-36, 2003.
DOI : 10.1136/jmg.40.1.34
URL : https://hal.archives-ouvertes.fr/inserm-00143439

N. Cariello, L. Cui, and C. Béroud, Database and software for the analysis of mutations in the human p53 gene, Cancer Res, vol.54, pp.4454-4460, 1994.

C. Béroud, G. Collod-béroud, and C. Boileau, UMD (Universal Mutation Database): A generic software to build and analyze locus-specific databases, Human Mutation, vol.3, issue.1, pp.86-94, 2000.
DOI : 10.1093/hmg/3.4.635

C. Béroud and T. Soussi, p53 gene mutation: software and database, Nucleic Acids Research, vol.26, issue.1, pp.200-204, 1998.
DOI : 10.1093/nar/26.1.200

C. Béroud and T. Soussi, APC gene: database of germline and somatic mutations in human tumors and cell lines, Nucleic Acids Research, vol.24, issue.1, pp.121-124, 1996.
DOI : 10.1093/nar/24.1.121

P. Laurent-puig, C. Béroud, and T. Soussi, APC gene: database of germline and somatic mutations in human tumors and cell lines, Nucleic Acids Research, vol.26, issue.1, pp.269-270, 1998.
DOI : 10.1093/nar/26.1.269

C. Béroud, D. Joly, and C. Gallou, Software and database for the analysis of mutations in the VHL gene, Nucleic Acids Research, vol.26, issue.1, pp.256-258, 1998.
DOI : 10.1093/nar/26.1.256

C. Gallou, D. Joly, and A. Méjean, Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC, Human Mutation, vol.8, issue.6, pp.464-475, 1999.
DOI : 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3

C. Jeanpierre, C. Béroud, and P. Niaudet, Software and database for the analysis of mutations in the human WT1 gene, Nucleic Acids Research, vol.26, issue.1, pp.271-274, 1998.
DOI : 10.1093/nar/26.1.271

M. Varret, J. Rabes, and G. Collod-béroud, Software and database for the analysis of mutations in the human LDL receptor gene, Nucleic Acids Research, vol.25, issue.1, pp.172-80, 1997.
DOI : 10.1093/nar/25.1.172
URL : https://hal.archives-ouvertes.fr/inserm-00143593

M. Varret, J. Rabes, and R. Thiart, LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis, Nucleic Acids Research, vol.26, issue.1, pp.248-252, 1998.
DOI : 10.1093/nar/26.1.248

L. Villeger, M. Abifadel, and D. Allard, The UMD-LDLR database: additions to the software and 490 new entries to the database, Human Mutation, vol.39, issue.2, pp.81-87, 2002.
DOI : 10.1016/0092-8674(84)90188-0

G. Collod, C. Béroud, and T. Soussi, Software and database for the analysis of mutations in the human FBN1 gene, Nucleic Acids Research, vol.24, issue.1, pp.137-140, 1996.
DOI : 10.1093/nar/24.1.137
URL : https://hal.archives-ouvertes.fr/inserm-00143165

G. Collod-béroud, C. Béroud, and L. Ades, Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene, Nucleic Acids Research, vol.25, issue.1, pp.147-50, 1997.
DOI : 10.1093/nar/25.1.147

G. Collod-béroud, C. Béroud, and L. Ades, Marfan Database (third edition): new mutations and new routines for the software, Nucleic Acids Research, vol.26, issue.1, pp.229-232, 1998.
DOI : 10.1093/nar/26.1.229

G. Collod-béroud, L. Bourdelles, and L. Ades, New update of the UMD-FBN1 mutation database and creation of a FBN1 polymorphism database, Hum Mutat, 2003.

J. Den-dunnen and S. Antonarakis, Nomenclature for the description of human sequence variations, Human Genetics, vol.109, issue.1, pp.121-125, 2001.
DOI : 10.1007/s004390100505

L. Pereira, D. 'alessio, M. Ramirez, and F. , Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome, Human Molecular Genetics, vol.2, issue.7, pp.961-968, 1993.
DOI : 10.1093/hmg/2.7.961

T. Aoyama, U. Francke, and H. Dietz, Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms., Journal of Clinical Investigation, vol.94, issue.1, pp.130-137, 1994.
DOI : 10.1172/JCI117298

G. Nijbroek, S. Sood, and I. Mcintosh, Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons, Am J Hum Genet, vol.57, pp.8-21, 1995.

I. Schrijver, W. Liu, and R. Odom, Premature Termination Mutations in FBN1: Distinct Effects on Differential Allelic Expression and on Protein and Clinical Phenotypes, The American Journal of Human Genetics, vol.71, issue.2, pp.223-237, 2002.
DOI : 10.1086/341581

K. Rommel, M. Karck, and A. Haverich, Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with Marfan syndrome or Marfanoid features leads to the identification of 11 novel and three previously reported mutations, Human Mutation, vol.20, issue.5, pp.406-407, 2002.
DOI : 10.1002/humu.9075

M. Wang, P. Kishnani, and M. Decker-phillips, Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome., Journal of Medical Genetics, vol.33, issue.9, pp.760-763, 1996.
DOI : 10.1136/jmg.33.9.760

F. Tiecke, P. Robinson, and P. Booms, Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype???phenotype correlations in FBN1 exons??24???40, European Journal of Human Genetics, vol.9, issue.1, pp.13-21, 2001.
DOI : 10.1038/sj.ejhg.5200582
URL : http://www.nature.com/ejhg/journal/v9/n1/pdf/5200582a.pdf

H. Dietz, D. Valle, and C. Francomano, The skipping of constitutive exons in vivo induced by nonsense mutations, Science, vol.267, issue.4, pp.680-683, 1993.
DOI : 10.1128/MCB.9.7.2868

B. Loeys, L. Nuytinck, and I. Delvaux, Genotype and Phenotype Analysis of 171 Patients Referred for Molecular Study of the Fibrillin-1 Gene FBN1 Because of Suspected Marfan Syndrome, Archives of Internal Medicine, vol.161, issue.20, pp.2447-54, 2001.
DOI : 10.1001/archinte.161.20.2447

S. Reber-müller, T. Spissinger, and P. Schuchert, An Extracellular Matrix Protein of Jellyfish Homologous to Mammalian Fibrillins Forms Different Fibrils Depending on the Life Stage of the Animal, Developmental Biology, vol.169, issue.2, pp.662-672, 1995.
DOI : 10.1006/dbio.1995.1177

R. Doolittle, Reconstructing history with amino acid sequences1, Protein Science, vol.2, issue.2, pp.191-200, 1992.
DOI : 10.1128/jb.173.8.2506-2513.1991
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2142198/pdf

K. Kainulainen, L. Sakai, and A. Child, Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides., Proceedings of the National Academy of Sciences, vol.89, issue.13, pp.5917-5921, 1992.
DOI : 10.1073/pnas.89.13.5917
URL : http://www.pnas.org/content/89/13/5917.full.pdf

W. Liu, I. Schrijver, and T. Brenn, Multi-exon deletions of the FBN1 gene in Marfan syndrome, BMC Med Genet, vol.2, issue.1, p.1, 2001.

L. Karttunen, T. Ukkonen, and K. Kainulainen, Two novel fibrillin-1 mutations resulting in premature termination codons but in different mutant transcript levels and clinical phenotypes, Human Mutation, vol.4, issue.S1, pp.34-37, 1998.
DOI : 10.1093/hmg/4.4.607

M. Krawczak and D. Cooper, Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment, Human Genetics, vol.86, issue.5, pp.425-441, 1991.
DOI : 10.1007/BF00194629

T. Cooper and W. Mattox, The Regulation of Splice-Site Selection, and Its Role in Human Disease, The American Journal of Human Genetics, vol.61, issue.2, pp.259-266, 1997.
DOI : 10.1086/514856

H. Dietz, I. Mcintosh, and L. Sakai, Four Novel FBN1 Mutations: Significance for Mutant Transcript Level and EGF-like Domain Calcium Binding in the Pathogenesis of Marfan Syndrome, Genomics, vol.17, issue.2, pp.468-475, 1993.
DOI : 10.1006/geno.1993.1349

W. Liu, C. Qian, and U. Francke, Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome, Nature Genetics, vol.238, issue.4, pp.328-337, 1997.
DOI : 10.1038/ng0395-232

H. Dietz and R. Kendzior, Maintenance of an open reading frame as an additional level of scrutiny during splice site selection, Nature Genetics, vol.200, issue.2, pp.183-191, 1994.
DOI : 10.1038/352337a0

M. Caputi, R. Kendzior, and K. Beemon, A nonsense mutation in the fibrillin-1 gene of a Marfan syndrome patient induces NMD and disrupts an exonic splicing enhancer, Genes & Development, vol.16, issue.14, pp.1754-1763, 2002.
DOI : 10.1101/gad.997502

P. Frischmeyer and H. Dietz, Nonsense-mediated mRNA decayin health and disease, Human Molecular Genetics, vol.8, issue.10, pp.1893-1900, 1999.
DOI : 10.1093/hmg/8.10.1893
URL : https://academic.oup.com/hmg/article-pdf/8/10/1893/6754826/8-10-1893.pdf

T. Aoyama, K. Tynan, and H. Dietz, Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome, Human Molecular Genetics, vol.2, issue.12, pp.2135-2140, 1993.
DOI : 10.1093/hmg/2.12.2135

D. Halliday, S. Hutchinson, and S. Kettle, Molecular analysis of eight mutations in FBN1, Human Genetics, vol.105, issue.6, pp.587-597, 1999.
DOI : 10.1007/s004399900190

I. Schrijver, W. Liu, and T. Brenn, Cysteine Substitutions in Epidermal Growth Factor???Like Domains of Fibrillin-1: Distinct Effects on Biochemical and Clinical Phenotypes, The American Journal of Human Genetics, vol.65, issue.4, pp.1007-1027, 1999.
DOI : 10.1086/302582

A. Johnson and N. Haigh, The ER Translocon and Retrotranslocation, Cell, vol.102, issue.6, pp.709-712, 2000.
DOI : 10.1016/S0092-8674(00)00059-3
URL : https://doi.org/10.1016/s0092-8674(00)00059-3

J. Lippincott-schwartz, T. Roberts, and K. Hirshberg, Secretory Protein Trafficking and Organelle Dynamics in Living Cells, Annual Review of Cell and Developmental Biology, vol.16, issue.1, pp.557-589, 2000.
DOI : 10.1146/annurev.cellbio.16.1.557
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781643/pdf

J. Lord, J. Davey, and L. Frigerio, Endoplasmic reticulum-associated protein degradation, Seminars in Cell & Developmental Biology, vol.11, issue.3, pp.159-164, 2000.
DOI : 10.1006/scdb.2000.0160

A. Downing, V. Knott, and J. Werner, Solution Structure of a Pair of Calcium-Binding Epidermal Growth Factor-like Domains: Implications for the Marfan Syndrome and Other Genetic Disorders, Cell, vol.85, issue.4, pp.597-605, 1996.
DOI : 10.1016/S0092-8674(00)81259-3

V. Knott, A. Downing, and C. Cardy, Calcium Binding Properties of an Epidermal Growth Factor-like Domain Pair from Human Fibrillin-1, Journal of Molecular Biology, vol.255, issue.1, pp.22-29, 1996.
DOI : 10.1006/jmbi.1996.0003

C. Cardy and P. Handford, Metal ion dependency of microfibrils supports a rod-like conformation for fibrillin-1 calcium-binding epidermal growth factor-like domains 1 1Edited by M. F. Moody, Journal of Molecular Biology, vol.276, issue.5, pp.855-60, 1998.
DOI : 10.1006/jmbi.1997.1593

G. Collod-béroud and C. Boileau, Marfan syndrome in the third Millennium, European Journal of Human Genetics, vol.15, issue.11, pp.673-681, 2003.
DOI : 10.1002/pd.1970151217

P. Robinson, P. Booms, and S. Katzke, Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies, Human Mutation, vol.432, issue.3, pp.153-61, 2002.
DOI : 10.1161/01.CIR.94.11.2708

M. Palz, F. Tiecke, and P. Booms, Clustering of mutations associated with mild Marfan-like phenotypes in the 3? region ofFBN1 suggests a potential genotype-phenotype correlation, American Journal of Medical Genetics, vol.129, issue.3, pp.212-233, 2000.
DOI : 10.1083/jcb.129.4.1165